1. A novel prognostic inflammation score predicts outcomes in patients with ovarian cancer
   Yuan-qiu Wang et al, 2016, Clinica Chimica Acta CrossRef
2. Combined Detection of C-Reactive Protein and Serum Amyloid A Based on Up-Conversion Luminescent System for Internet of Medical Things Application
   Chi Song et al, 2021, IEEE Transactions on Nanotechnology CrossRef
3. Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer
   Katharina Auer et al, 2016, Oncotarget CrossRef
4. Association between C-reactive protein level and subsequent risk of ovarian cancer
   Yan Wang et al, 2020, Medicine CrossRef
5. Efficacy of vasopressin V2 receptor antagonist tolvaptan in treatment of hepatic edema
   Yasunari Hiramine et al, 2017, Hepatology Research CrossRef
6. The postoperative peak number of leukocytes after hepatectomy is a significant prognostic factor for cholangiocarcinoma
   Go Shinke et al, 2019, Molecular and Clinical Oncology CrossRef
7. Preoperative Measurement of Serum C-Reactive Protein: Is it Useful in the Differential Diagnosis of Adnexal Masses?
   Adriana Yoshida et al, 2017, The International Journal of Biological Markers CrossRef
8. The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study
   Jiayu Zhu et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
9. The association between the inflammatory potential of diet and risk of developing, and survival following, a diagnosis of ovarian cancer
   null null et al, 2019, European Journal of Nutrition CrossRef
10. Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis
    Wei Zhang et al, 2024, World Journal of Surgical Oncology CrossRef
11. C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis
    Yingying Yang et al, 2022, Computational Intelligence and Neuroscience CrossRef
12. Procalcitonin and C‐reactive protein as early markers of anastomotic leakage in intestinal resections for advanced ovarian cancer (EDMOCS)
    José Luis Sánchez‐Iglesias et al, 2024, Acta Obstetricia et Gynecologica Scandinavica CrossRef
13. Implementation of Proteomics in Clinical Trials
    Tianlin He, 2019, PROTEOMICS – Clinical Applications CrossRef
14. Ascitic Fluid in Ovarian Carcinoma – From Pathophysiology to the Treatment
    Radomir Živadinović et al, 2017, Ascites - Physiopathology, Treatment, Complications and Prognosis CrossRef
15. The Role of Perioperative C-Reactive Protein in Predicting the Prognosis of Epithelial Ovarian Carcinoma
    Qianqian Pan et al, 2023, Cancer Management and Research CrossRef